VSee Health, Inc.
VSEE
$0.67
$0.00010.02%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 170.29% | 131.10% | 32.66% | -6.28% | -6.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 170.29% | 131.10% | 32.66% | -6.28% | -6.66% |
| Cost of Revenue | 252.79% | 96.78% | 2.59% | -32.85% | 1.50% |
| Gross Profit | 137.60% | 147.97% | 50.13% | 8.70% | -9.54% |
| SG&A Expenses | 309.31% | 210.79% | 1.17% | -35.37% | -29.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 296.29% | 179.02% | 1.53% | -34.71% | -24.07% |
| Operating Income | -840.50% | -441.20% | 65.97% | 110.87% | 57.94% |
| Income Before Tax | -1,328.84% | -15,639.27% | -331.71% | 104.57% | 67.58% |
| Income Tax Expenses | -52.73% | -135.34% | -1,185.09% | -- | 574.03% |
| Earnings from Continuing Operations | -104.85% | -52,386.31% | 15.54% | 106.40% | -506.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 700.00% | -766.67% | -587.76% |
| Net Income | -102.37% | -46,522.97% | 22.28% | 99.38% | -507.17% |
| EBIT | -840.50% | -441.20% | 65.97% | 110.87% | 57.94% |
| EBITDA | -638.00% | -196.53% | 66.20% | 110.98% | -- |
| EPS Basic | -28.10% | -30,822.52% | 32.02% | 99.33% | -507.44% |
| Normalized Basic EPS | -420.07% | 884.65% | -136.83% | 100.81% | 43.87% |
| EPS Diluted | -28.13% | -30,822.52% | 32.02% | 99.33% | -507.44% |
| Normalized Diluted EPS | -420.07% | 884.65% | -136.83% | 100.81% | 43.87% |
| Average Basic Shares Outstanding | 58.01% | 50.80% | 14.29% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 58.01% | 50.80% | 14.29% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |